Tag: III
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study – BioSpace
eczemarelief
September 5, 2025
Copy of – Reistone reports positive phase III results for ivarmacitinib in atopic dermatitis
eczemarelief
November 22, 2022